Metipranolol (Optipranololr̀) is a new ophthalmic nonselective beta-blocker introduced by Bausch and Lomb Pharmaceuticals. Its chemical name is metipranolol hydrochloride or 1-(4-hydroxy-2,3,5-trimethylphenoxy)-3(isopropylaninol)-2-pro-panolol 4-acetate. 1 It is marketed as a 0.3% solution and has the advantage of a decreased cost compared to the other commercially available beta blockers. It is indicated in the treatment of ocular conditions in which lowering intraocular pressure (IOP) is likely to be of therapeutic benefit: in patients with ocular hypertension and patients with chronic open angle glaucoma.
ASJC Scopus subject areas